Envista (NYSE:NVST) Announces Earnings Results

Envista (NYSE:NVST) released its earnings results on Wednesday. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07, FiscalAI reports. The business had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. The business’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the company posted $0.26 EPS. Envista updated its FY 2026 guidance to 1.500-1.550 EPS.

Here are the key takeaways from Envista’s conference call:

• Strong second-quarter results: Envista delivered 5% core sales growth, 28% adjusted EBITDA growth, 58% adjusted EPS growth to $0.41, and 158% free-cash-flow conversion. Growth was broad-based across both reporting segments and major geographies.
• Full-year guidance was raised and narrowed to 3.5%-4.5% core growth, 11%-14% adjusted EBITDA growth, and adjusted EPS of $1.50-$1.55; the expected tax rate was also reduced to approximately 26% from prior guidance.
• Equipment & Consumables grew 8.5% organically, supported by high-single-digit growth in consumables and diagnostics, continued share gains, pricing, and new products. Spark again grew at a double-digit rate, while new implant, orthodontic, and consumable product launches are intended to support future growth.
• Operational execution continued to improve profitability, with adjusted EBITDA margin expanding 230 basis points to 14.7% through manufacturing productivity, G&A savings, pricing, and favorable volume mix. The company also repurchased approximately 2.4 million shares and ended the quarter with net debt of 0.7 times adjusted EBITDA.
• Management expects slower reported growth in the second half, including flat to slightly negative core growth in the fourth quarter because of four fewer selling days. China’s upcoming ortho and implant volume-based procurement programs are expected to create significant price pressure, including roughly 10%-15% implant price compression and potentially greater pressure in orthodontics.

Envista Trading Up 2.0%

NVST traded up $0.55 on Wednesday, hitting $28.51. The company had a trading volume of 6,998,014 shares, compared to its average volume of 2,798,520. The firm has a market cap of $4.64 billion, a P/E ratio of 69.54, a PEG ratio of 1.58 and a beta of 0.86. Envista has a 1 year low of $18.77 and a 1 year high of $30.42. The company’s fifty day moving average price is $25.87 and its 200 day moving average price is $25.99. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47.

Trending Headlines about Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Envista reported second-quarter adjusted earnings of $0.41 per share, exceeding the $0.33–$0.34 analyst consensus and rising from $0.26 in the year-ago quarter. Envista Q2 earnings and revenues surpass estimates
• Positive Sentiment: Revenue increased 7.1% year over year to $730.5 million, beating estimates of approximately $716.1 million. Both sales and earnings exceeded expectations, indicating stronger quarterly execution. Envista Q2 Earnings Snapshot
• Positive Sentiment: Management provided fiscal 2026 EPS guidance of $1.50 to $1.55, above the current consensus estimate of $1.43. The outlook suggests investors may need to raise their earnings expectations for the year. Envista Q2 2026 earnings
• Neutral Sentiment: Despite the earnings beat, Envista reported a relatively modest 2.41% net margin and 7.11% return on equity. Investors may focus on whether improved revenue growth can translate into sustained margin expansion. Envista Q2 key metrics versus estimates

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Morgan Stanley boosted their price objective on Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, April 24th. Weiss Ratings lowered Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. BMO Capital Markets began coverage on shares of Envista in a report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price objective for the company. Citigroup began coverage on shares of Envista in a research report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price objective for the company. Finally, Wall Street Zen lowered shares of Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Six equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $28.62.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after acquiring an additional 1,504 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after purchasing an additional 949 shares during the period. UMB Bank n.a. lifted its stake in Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after purchasing an additional 636 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Envista by 378.0% during the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after buying an additional 1,909 shares during the period. Finally, Quarry LP acquired a new stake in shares of Envista in the third quarter valued at $66,000.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.